Fecal Microbiota Transplant (FMT) Capsule for Improving the Efficacy of GI-aGVHD

Summary

This study aims to determine whether the fecal microbiota transplant (FMT) capsule improves the response rate of GI-aGVHD in patients with glucocorticoid-refractory acute graft vs. host disease after allogeneic stem cell transplantation

Timeline

Start

2021-11-01

Primary completion

2023-03-02

Completion

2023-03-02

Drugs

Indications